Advertising Disclosure

Medicare recipients will pay more for drug coverage in 2026

A subsidy that helped control costs in 2025 is going away

Updated:

Avatar photo
By:
Avatar photo

Mark Huffman
Reporter

Mark Huffman has covered consumer issues since 2004, with a special focus on protecting and empowering older adults. A former news correspondent for the Associated Press Radio Network, Westwood One, and ConsumerAffairs, Mark brings decades of journalistic experience to RetirementLiving.com. He is passionate about giving consumers a voice and helping them make informed decisions. Mark has also created educational content, including Senior Scam Alert, a video resource designed to help seniors recognize and avoid fraud. He holds a B.A. from the University of Kentucky and lives with his family in Richmond, Virginia.

Key Insights

  • Medicare Part D premiums are likely to rise as a key federal subsidy is scaled back.
  • The Trump administration plans to cut the subsidy program by 40% after it held premiums down in 2025.
  • Officials and insurers brace for cost hikes driven by inflation, policy changes, and rising drug spending.

Millions of seniors who get their prescription drug coverage through Medicare should brace for a sharp rise in premiums in 2026. A major federal subsidy program introduced just last year faces a significant reduction. 

The temporary financial support, credited with keeping premiums affordable in 2025, is set to be scaled back under new budget plans crafted by the Trump administration.

In 2025, the government injected $6.2 billion into Medicare Part D plans, trying to cushion seniors from ballooning prescription drug costs. The temporary boost held monthly premiums for basic drug plans at an average of $36—roughly 20% lower than projected without the aid, according to Avalere Health, cited in a report by the Wall Street Journal.

But the reprieve will be fleeting. Federal officials have confirmed that, starting in 2026, the monthly subsidy provided to insurers will drop from $15 to $10 per enrollee—a 40% reduction. 

The decision, made by the Centers for Medicare and Medicaid Services (CMS), reflects broader efforts to rebalance taxpayer spending and insurer responsibility.

“This is all about trying to maintain affordability against a massively increasing backdrop of expense,” said Chris Klomp, director of the Center for Medicare. Klomp added that continuing the full subsidy would have disproportionately benefited a few insurers at a steep cost to taxpayers.

Larger premiums for stand-alone Par D plans

The impact of the subsidy rollback will not be uniform. Analysts expect seniors in stand-alone Part D plans – often paired with traditional Medicare – will be hardest hit. Unlike Medicare Advantage plans, which typically bundle drug coverage into broader health benefits, stand-alone plans face fewer internal offsets to rising costs.

Under the updated framework:

  • The cap on annual premium hikes will rise from $35 in 2025 to $50 in 2026.
  • Insurers will shoulder a larger share of financial risk as federal protections against major losses are scaled back.
  • The reduced subsidies will trim only about $13.50/month on average from premium increases.

For seniors on fixed incomes, the increases could represent a significant strain, especially for those managing multiple chronic conditions or expensive medications.

What seniors can do

Seniors are urged to carefully review their options during the 2025 open enrollment period. Comparing plans, and factoring in out-of-pocket costs, not just premiums, will be more important than ever.

Resources like the Medicare Plan Finder and state SHIP (State Health Insurance Assistance Program) counselors can help navigate the increasingly complex landscape.